MTOR and cancer: With regard to mTOR rs2295080, Zhu and colleagues conducted a meta-analysis of seven case–control studies and showed that mTOR rs2295080 may be associated with reduced cancer susceptibility in homozygous, heterozygous and dominant models [16].